Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic Sclerosis.
Chi-Square Distribution
Cohort Studies
Disability Evaluation
Female
Germany
Humans
Male
Middle Aged
Odds Ratio
Patient Acceptance of Health Care
/ statistics & numerical data
Physical Therapy Modalities
/ statistics & numerical data
Registries
Scleroderma, Systemic
/ pathology
Severity of Illness Index
Journal
Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
02
09
2018
accepted:
28
05
2019
pubmed:
1
6
2019
medline:
7
10
2020
entrez:
1
6
2019
Statut:
ppublish
Résumé
To determine the type and frequency of physical therapy (PT) prescribed by physicians for patients in the registry of the German Network for Systemic Sclerosis. The data for 4,252 patients were analyzed using descriptive statistics, chi-square tests, and odds ratios (ORs). Overall, 37.4% of patients (1,590 of 4,252) received PT at the end of a yearly follow-up. The most frequently used type of PT was lymphatic drainage (n = 1,061, 36.8%), followed by exercise therapy (n = 1,047, 36.3%) and heat therapy (n = 689, 23.9%). More than three-fourths of treated patients (82%) received 1 or 2 different forms of PT simultaneously. The prescription of PT was associated with the extent of skin fibrosis as measured by the modified Rodnan skin thickness score (<10 [41.8% of patients], 11-20 [55.8% of patients], and >21 [63.9% of patients]; P < 0.001). Patients with musculoskeletal involvement (e.g., arthritis, muscle weakness, joint contractures, tendon friction rubs) had a higher chance of receiving PT than patients without these symptoms, with corresponding ORs ranging from 1.96 (95% confidence interval [95% CI] 1.69-2.28) for joint contractures to 3.83 (95% CI 2.89-5.08) for arthritis. When comparing the type of PT prescription across the initial and all follow-up visits from 2003 to 2017, significant alterations with a decreasing frequency of patients receiving PT could be observed (P = 0.001). To our knowledge, this is the first study reporting the use of PT in patients with systemic sclerosis (SSc) in a large cohort. Although SSc is characterized by considerable disability and restriction of motion, <40% of patients received PT.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1041-1048Informations de copyright
© 2019, American College of Rheumatology.
Références
Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, et al. Vasoactive therapy in systemic sclerosis: real-life therapeutic practice in more than 3000 patients. J Rheumatol 2016;43:66-74.
Hunzelmann N, Moinzadeh P, Genth E, Krieg T, Lehmacher W, Melchers I, et al. High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy. Arthritis Res Ther 2009;11:R30.
Lange U, Tarner IH, Dischereit G, Müller-Ladner U. Molecular effects of physical therapy. What's new? Z Rheumatol 2015;74:226-9. In German.
Lange U, Rehart S. Significance and importance of physical medicine in the context of conservative therapy for rheumatic patients. Orthopaede 2013;42:813-21. In German.
Meier FM, Müller-Ladner U, Lange U. Efficacy of intensive physiotherapy in combination with low-dose etanercept in active spondyloarthritis: a monocentric pilot study. J Rheumatol 2014;41:1897-8.
Daien CI, Hua C, Combe B, Landewe R. Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis. RMD Open 2017;3:e000404.
Poole JL. Musculoskeletal rehabilitation in the person with scleroderma. Curr Opin Rheumatol 2010;22:205-12.
Maddali Bongi S, Del Rosso A, Galluccio F, Tai G, Sigismondi F, Passalacqua M, et al. Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp Rheumatol 2009;27:44-50.
Bongi SM, Del Rosso A, Galluccio F, Sigismondi F, Miniati I, Conforti ML, et al. Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clin Rheumatol 2009;28:1167-73.
Naylor WP, Douglass CW, Mix E. The nonsurgical treatment of microstomia in scleroderma: a pilot study. Oral Surg 1984;57:508-11.
Pils K, Graninger W, Sadil F. Paraffin hand bath for scleroderma. Euro J Phys Rehabil Med 1991;1:19-21.
Sandqvist G, Akesson A, Eklund M. Evaluation of paraffin bath treatment in patients with systemic sclerosis. Disabil Rehabil 2004;26:981-7.
Maddali-Bongi S, Del Rosso A. Systemic sclerosis: rehabilitation as a tool to cope with disability. Clin Exp Rheumatol 2016;34 Suppl 100:162-9.
Willems LM, Vriezekolk JE, Schouffoer AA, Poole JL, Stamm TA, Boström C, et al. Effectiveness of nonpharmacologic interventions in systemic sclerosis: a systematic review. Arthritis Care Res (Hoboken) 2015;67:1426-39.
Murphy SL, Barber MW, Homer K, Dodge C, Cutter GR, Khanna D. Occupational therapy treatment to improve upper extremity function in individuals with early systemic sclerosis: a pilot study. Arthritis Care Res (Hoboken) 2018;70:1653-60.
Landim SF, Bertolo MB, Marcatto de Abreu MF, Del Rio AP, Mazon CC, Marques-Neto JF, et al. The evaluation of a home-based program for hands in patients with systemic sclerosis. J Hand Ther 2019;32:313-21.
Horváth J, Bálint Z, Szép E, Deiszinger A, Minier T, Farkas N, et al. Efficacy of intensive hand physical therapy in patients with systemic sclerosis. Clin Exp Rheumatol 2017;35 Suppl 106:159-66.
De Oliveira NC, Portes LA, Pettersson H, Alexanderson H, Boström C. Aerobic and resistance exercise in systemic sclerosis: state of the art. Musculoskeletal Care 2017;15:316-23.
Stefanantoni K, Sciarra I, Iannace N, Vasile M, Caucci M, Sili Scavalli A, et al. Occupational therapy integrated with a self-administered stretching program on systemic sclerosis patients with hand involvement. Clin Exp Rheumatol 2016;34 Suppl 100:157-61.
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2017;76:1327-39.
Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 2008;47:1185-92.
Mierau R, Moinzadeh P, Riemekasten G, Melchers I, Meurer M, Reichenberger F, et al. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther 2011;13:172.
Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JH, Fierlbeck G, et al. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 2015;74:730-7.
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
Balbir-Gurman A, Braun-Moscovici Y. Scleroderma overlap syndrome. Isr Med Assoc J 2011;13:14-20.
Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2007;66:754-63.
World Confederation for Physical Therapy. Policy statement: description of physical therapy. Appendix 1. 2017. URL: www.wcpt.org/policy/ps-descriptionPT.
World Confederation for Physical Therapy. WCPT guideline for physical therapist professional entry level education. p. 21-9. 2011. URL: https://www.wcpt.org/sites/wcpt.org/files/files/Guideline_PTEducation_complete.pdf.
Rannou F, Boutron I, Mouthon L, Sanchez K, Tiffreau V, Hachulla E, et al. Personalized physical therapy versus usual care for patients with systemic sclerosis: a randomized controlled trial. Arthritis Care Res (Hoboken) 2017;69:1050-9.
Zink A, Listing J, Ziemer S, Zeidler H, and German Collaborative Arthritis Centres. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists. J Rheumatol 2001;28:2201-8.
Dowman LM, McDonald CF, Hill CJ, Lee AL, Barker K, Boote C, et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax 2017;72:610-9.
Curtis K, Hopkinson NS. Exercise training in interstitial lung disease: lumping or splitting? Thorax 2017;72:589-90.
Nakayama M, Bando M, Araki K, et al. Physical activity in patients with idiopathic pulmonary fibrosis. Respirology 2015;20:640-6.
Ryerson CJ, Cayou C, Topp F, Sekine T, Kurosaki F, Sawata T, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med 2014;108:203-10.
Babu AS, Arena R, Morris NR. Evidence on exercise training in pulmonary hypertension. Adv Exp Med Biol 2017;1000:153-72.
Leggio M, Fusco A, Limongelli G, Sgorbini L. Exercise training in patients with pulmonary and systemic hypertension: a unique therapy for two different diseases. Eur J Intern Med 2018;47:17-24.
Madden BP, Shaw EJ. Skeletal muscle exercise training in pulmonary arterial hypertension. Int J Cardiol 2017;246:59-60.
Keusch S, Turk A, Saxer S, Ehlken N, Grunig E, Ulrich S, on behalf of the Swiss Society of Pulmonary Hypertension. Rehabilitation in patients with pulmonary arterial hypertension. Swiss Med Wkly 2017;147:w14462.
González-Saiz L, Fiuza-Luces C, Sanchis-Gomar F, Santos-Lozano A, Quezada-Loaiza CA, Flox-Camacho A, et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. Int J Cardiol 2017;231:277-83.
Volkmann ER, Chung A, Tashkin DP. Managing systemic sclerosis-related interstitial lung disease in the modern treatment era. J Scleroderma Relat Disord 2017;2:72-83.
Da Fontoura FF, Berton DC, Watte G, Florian J, Schio SM, Camargo JJ, et al. Pulmonary rehabilitation in patients with advanced idiopathic pulmonary fibrosis referred for lung transplantation. J Cardiopulm Rehabil Prev 2018;38:131-4.
Gomes-Neto M, Silva CM, Ezequiel D, Conceição CS, Saquetto M, Machado AS. Impact of pulmonary rehabilitation on exercise tolerance and quality of life in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. J Cardiopulm Rehabil Prev 2018;38:273-8.